The use of nanotechnology offers new opportunities for the development of novel strategies in terms of prevention, diagnosis, and treatment viral infections.
This report contains market size and forecasts of Nanomaterials in Personalized Medicine in Global, including the following market information:
Global Nanomaterials in Personalized Medicine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Nanomaterials in Personalized Medicine market was valued at 291970 million in 2021 and is projected to reach US$ 529670 million by 2028, at a CAGR of 8.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Nano-Medicine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nanomaterials in Personalized Medicine include Abbott, Amgen, Biogen, Celgene, Gilead Sciences, Merck and Co, Pfizer, Roche and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nanomaterials in Personalized Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nanomaterials in Personalized Medicine Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Nanomaterials in Personalized Medicine Market Segment Percentages, by Type, 2021 (%)
Nano-Medicine
Nanometer Medical Instrument
Others
Global Nanomaterials in Personalized Medicine Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Nanomaterials in Personalized Medicine Market Segment Percentages, by Application, 2021 (%)
Anticancer
CNS Products
Anti-infection
Others
Global Nanomaterials in Personalized Medicine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Nanomaterials in Personalized Medicine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nanomaterials in Personalized Medicine revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Nanomaterials in Personalized Medicine revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Amgen
Biogen
Celgene
Gilead Sciences
Merck and Co
Pfizer
Roche
Sanofi
Stryker
Teva Pharmaceuticals